September 23, 2026
Company to Highlight Next Stage of PH-762 Clinical Development in Cutaneous Squamous Cell Carcinoma
Press Release
Read more
September 22, 2026
Podium presentation will detail AirSCWO performance across PFAS, tire-derived 6PPD-q, and pharmaceutical waste streams
Press Release
Read more
September 21, 2026
Live Presentations and Q&A Across Community and Regional Banking, Wealth Management, Logistics Real Estate, and Bitcoin Treasury Companies From US, UK and Canadian Markets Present Live Online, with Replays On Demand
Press Release
Read more
September 21, 2026
Clinical and Corporate Highlights Successfully listed on the Nasdaq Capital Market under the ticker symbol LABT, marking a significant milestone in the Company's evolution Strengthened balance sheet through completion of a $7.5 ...
Press Release
Read more
September 21, 2026
THOUSAND OAKS, CA
Press Release
Read more
September 21, 2026
Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement
Press Release
Read more
September 18, 2026
Lakewood-Amedex Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3
Press Release,
Featured Company,
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT)
Read more
September 17, 2026
Mineral Exploration Company Is Drilling in British Columbia and Has Acquired an Advanced Phosphate Project in Utah
Press Release
Read more